文献速递妇科

氧化应激在卵巢癌发病机制中作用的最新进展

Updates of the role of oxidative stress in the pathogenesis of ovarian cancer.
PubMed 文献 · Gynecol Oncol · 2017-02-23

本综述基于最新实验与临床观察,汇总氧化应激在卵巢癌发病机制、新生血管形成及播散中的作用,并讨论氧化应激标志物与上皮性卵巢癌分期的关系及其作为治疗干预和早期检测生物标志物的潜力。

要点

  • 氧化应激在卵巢癌发病机制、新生血管形成及局部或远处播散中起重要作用。
  • 氧化应激通过肿瘤细胞与周围间质的交互作用诱导肿瘤细胞表型改变。
  • 氧化应激标志物与上皮性卵巢癌各分期的关系具有治疗干预和早期检测生物标志物的潜在价值。

核心结论

  • 氧化应激在卵巢癌发病机制、新生血管形成及播散中起重要作用,氧化应激标志物与上皮性卵巢癌分期的关系突显潜在治疗干预和早期检测生物标志物的价值。

研究设计与样本

  • 综述,基于作者科研工作及最新实验与临床观察,汇总氧化应激在卵巢癌发病机制中作用的相关发现。

主要发现

  • 慢性炎症、感染和缺氧等外源性因素是细胞氧化应激的主要来源。
  • 氧化应激通过肿瘤细胞与周围间质的交互作用诱导肿瘤细胞表型改变,参与卵巢癌发病机制、新生血管形成及局部或远处播散。
  • 氧化应激标志物与上皮性卵巢癌各分期的关系具有潜在治疗干预和早期检测生物标志物意义。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Clinical and epidemiological investigations have provided evidence supporting the role of reactive oxygen species (ROS) and reactive nitrogen species (RNS), collectively known as oxidative stress, in the etiology of cancer. Exogenous factors such as chronic inflammation, infection and hypoxia are major sources of cellular oxidative stress. Specifically, oxidative stress plays an important role in the pathogenesis, neoangiogenesis, and dissemination of local or distant ovarian cancer, as it is known to induce phenotypic modifications of tumor cells by cross talk between tumor cells and the surrounding stroma. Subsequently, the biological significance of the relationship between oxidative stress markers and various stages of epithelial ovarian cancer highlights potential therapeutic interventions as well as provides urgently needed early detection biomarkers. In the light of our scientific research and the most recent experimental and clinical observations, this review provides the reader with up to date most relevant findings on the role of oxidative stress in the pathogenesis of ovarian cancer and the possible therapeutic implications.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Saed GM, Diamond MP, Fletcher NM, et al. Updates of the role of oxidative stress in the pathogenesis of ovarian cancer. Gynecol Oncol. 2017. PMID: 28237618. doi:10.1016/j.ygyno.2017.02.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。